Qualifying conditions for an Oklahoma medical marijuana card

Oklahoma has no fixed list of qualifying conditions

Most medical cannabis states limit eligibility to a list of diagnoses written into law. Oklahoma doesn't. State Question 788, approved by voters in June 2018, lets a licensed physician recommend medical marijuana to any patient when doing so is consistent with accepted standards of medical care. That makes Oklahoma one of the most physician-directed programs in the country.

In practice, your eligibility depends on a genuine clinical assessment, not on matching a diagnosis to a list. It also means the quality of that assessment matters: a recommendation from a careful physician is more likely to be accepted, and more likely to lead to safe, effective use.

How our physicians decide

During your visit, the physician considers the same factors they would for any treatment decision:

• Your symptoms and their impact. How long they've lasted, how severe they are, and how they affect sleep, work, relationships and daily life.
• What you've already tried. Prior medications, therapy, physical therapy or procedures, and why they did or didn't work or caused side effects.
• Your current medications. Cannabis can interact with blood thinners, sedatives, some seizure medications, and other drugs processed by the liver.
• Your risk factors. Such as a personal or family history of psychosis, heart disease, pregnancy, or a substance use disorder.
• Your goals. Reducing pain enough to sleep, cutting back on another medication, or managing nausea during treatment all call for different approaches.

If the physician concludes cannabis is reasonable and the potential benefit outweighs the risk, they sign your recommendation. If not, they'll explain why and suggest other options.

Commonly evaluated conditions

These are the conditions patients most often bring to our physicians. The list is not exhaustive and does not guarantee approval.

Condition-by-condition guide

Here's how our physicians typically think about the conditions we see most. This is general education, not a treatment plan; your physician tailors advice to you.

Chronic pain

Chronic pain is the most common reason Oklahomans seek a card, and it has the strongest research support. Physicians look at the type of pain (nerve, joint, muscle or mixed), its duration, and current pain medications. Many patients use cannabis alongside other treatment, and some find they can reduce their reliance on opioids or NSAIDs, which should always be done with their prescribing doctor.

Arthritis

Osteoarthritis and rheumatoid arthritis cause joint pain and stiffness that often worsen at night. Patients commonly ask about topical products for localized pain and oral products for sleep. Evidence for topicals is still limited, but they carry little risk of impairment.

Neuropathy

Nerve pain from diabetes, chemotherapy, injury or shingles often responds poorly to standard medications. Several clinical trials of inhaled cannabis have shown modest reductions in neuropathic pain. Physicians screen for interactions with gabapentin, pregabalin or antidepressants used for nerve pain.

Anxiety

Anxiety is common and evaluated carefully. THC can relieve anxiety at low doses but worsen it at higher doses, so physicians often discuss CBD-dominant or balanced products and very gradual dose increases. Cannabis is not a substitute for therapy or treatment of a severe anxiety disorder.

Insomnia

Trouble falling or staying asleep is often tied to pain, anxiety or another condition. Some patients report better sleep in the short term. Physicians discuss timing, avoiding daily high-dose use that can lead to tolerance, and rebound insomnia that can occur when stopping.

PTSD

Many veterans and trauma survivors report that cannabis eases nightmares, hyperarousal and sleep problems. Controlled research is mixed. Physicians consider cannabis as one part of a broader plan that ideally includes trauma-focused therapy.

Migraines and chronic headaches

Patients with frequent migraines often seek alternatives when triptans or preventive medications aren't enough. Observational studies suggest some patients experience fewer or less severe attacks. Physicians watch for medication-overuse patterns.

Fibromyalgia

Widespread pain, fatigue and poor sleep make fibromyalgia hard to treat. Research suggests possible benefits for sleep and pain in some patients. Physicians usually recommend starting with low doses in the evening.

Crohn's disease and ulcerative colitis

Patients often report relief from cramping, pain, nausea and poor appetite. Studies show symptom improvement in some people, but not reduced inflammation, so cannabis should never replace prescribed treatment for inflammatory bowel disease.

Cancer and treatment side effects

Cannabinoids have strong evidence for chemotherapy-induced nausea and vomiting, and can help appetite, pain and sleep. Physicians coordinate carefully with oncology care and screen for interactions with cancer medications.

Multiple sclerosis

Evidence supports cannabinoids for patient-reported muscle spasticity in MS. Physicians discuss balanced THC and CBD products and how to avoid impairment that affects balance and mobility.

Seizure disorders

A purified CBD medication (Epidiolex) is FDA-approved for certain severe seizure disorders. Over-the-counter and dispensary products vary widely in potency and purity, and CBD interacts with some seizure medications, so physicians strongly advise close coordination with a neurologist.

What the research shows

We believe patients should know how strong the evidence is for their condition. The most widely cited review, from the National Academies of Sciences, Engineering, and Medicine (2017), found:

• Conclusive or substantial evidence that cannabis or cannabinoids are effective for chronic pain in adults, chemotherapy-induced nausea and vomiting, and patient-reported muscle spasticity in multiple sclerosis.
• Moderate evidence for improving short-term sleep outcomes in people with conditions such as fibromyalgia, chronic pain and multiple sclerosis.
• Limited or insufficient evidence for many other uses, including anxiety, PTSD and depression, though research is ongoing and many patients report benefit.

Evidence gaps don't rule out a recommendation, but they shape how your physician talks with you about expectations, dosing and follow-up.

THC, CBD and product types

THC is the main intoxicating compound in cannabis and drives most of its effects on pain, nausea, appetite and sleep, along with side effects like impairment, dizziness and anxiety at higher doses. CBD is non-intoxicating and may help with anxiety and some types of pain and seizures. Many patients do best with products that combine both.

The general rule our physicians teach: start low, go slow. Begin with the smallest practical dose, wait long enough to feel the full effect, and increase gradually.

When cannabis may not be a fit

A responsible evaluation includes reasons to hold back. Our physicians take extra care, and may decline to recommend, when a patient:

• Is pregnant, trying to conceive or breastfeeding
• Has a personal or strong family history of schizophrenia or other psychotic disorders
• Has unstable heart disease or a recent cardiac event
• Has an active substance use disorder
• Takes medications with significant interaction risk, such as warfarin, certain seizure drugs or high-dose sedatives
• Works in a federally regulated safety-sensitive job, such as commercial driving or piloting, where any THC use can end a career

Cannabis can also cause cannabis hyperemesis syndrome (repeated severe vomiting) in some frequent users, and dependence in a minority of regular users. Your physician will explain warning signs.

Preparing for your visit

• A valid Oklahoma driver's license or state ID
• A list of current medications and supplements, with doses
• Any records you have, such as imaging reports, specialist notes or discharge summaries (helpful, not required)
• Notes on what you've already tried and how it worked
• A quiet, private place with a camera-enabled phone or computer

Patients under 18

Minors can hold an Oklahoma patient license, but OMMA requires signatures from two physicians, and a parent or legal guardian must be part of the application. Minor patients may not smoke or vaporize medical marijuana unless both recommending physicians agree it's medically necessary, and they may not enter dispensaries without their authorized parent or guardian. A minor license lasts up to two years or until the patient turns 18. Please contact us before booking for a minor so we can explain what's needed.

Questions about qualifying

Sources

1. Oklahoma State Question 788 (2018) and Title 63, Oklahoma Statutes, § 420 et seq.
2. Oklahoma Senate Bill 1066 (2025), recommending physician registration and education requirements.
3. OMMA: Physicians and OMMA: Patient Licenses, accessed September 2026.
4. National Academies of Sciences, Engineering, and Medicine. The Health Effects of Cannabis and Cannabinoids. Washington, DC: National Academies Press; 2017.
5. U.S. Food and Drug Administration. FDA approval of Epidiolex (cannabidiol), 2018.